Mindfulness-Based Cognitive Behavioral Program for People With Diabetes Mellitus
Effectiveness of A Mindfulness-Based Cognitive Behavioral Program on Quality of Life and Glycosylated Hemoglobin Control of People With Diabetes: A Randomized Controlled Trial in Damascus, Syria.
1 other identifier
interventional
40
1 country
1
Brief Summary
This randomized controlled trial evaluated the effectiveness of a mindfulness-based cognitive behavioral program in improving quality of life and glycemic control among adults with diabetes mellitus in Damascus, Syria. The intervention combined cognitive behavioral strategies and mindfulness practices and was delivered through 14 weekly sessions over approximately three months. Quality of life was assessed using the WHOQOL-BREF, and glycemic control was assessed using glycated hemoglobin (HbA1c) levels. The study compared participants receiving the intervention with a control group receiving routine diabetes care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes-mellitus
Started Oct 2025
Shorter than P25 for not_applicable diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 26, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2026
CompletedFirst Submitted
Initial submission to the registry
August 17, 2026
CompletedFirst Posted
Study publicly available on registry
August 21, 2026
CompletedAugust 27, 2026
August 1, 2026
3 months
August 17, 2026
August 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Glycated Hemoglobin (HbA1c) Level
Change in HbA1c level from baseline to immediately after completion of the intervention.
Baseline and 3 months (post-intervention).
Secondary Outcomes (1)
Within-group change in Quality of Life Measured by the World Health Organization Quality of Life-BREF (WHOQOL-BREF) Questionnaire
Baseline and 3 months (evaluated in the intervention arm).
Study Arms (2)
Mindfulness-Based Cognitive Behavioral Intervention
EXPERIMENTALParticipants received a structured mindfulness-based cognitive behavioral program consisting of 14 weekly sessions over approximately three months, in addition to routine diabetes care.
Routine Diabetes Care (Control)
NO INTERVENTIONParticipants received routine diabetes care without any additional psychological or behavioral intervention during the study period.
Interventions
Participants in the intervention group received a structured mindfulness-based cognitive behavioral program consisting of 14 weekly sessions delivered over approximately three months. Each session lasted approximately 90 minutes, including a 15-minute break. The program incorporated psychoeducation, cognitive restructuring, mindfulness exercises, behavioral activation, emotional regulation, relaxation techniques, coping strategies, and home practice assignments. The intervention was delivered by qualified mental health professionals in addition to routine diabetes care.
Eligibility Criteria
You may qualify if:
- Adults aged 18-70 years.
- Diagnosis of type 1 or type 2 diabetes mellitus.
- Baseline HbA1c level greater than 6.5%.
- Mild to moderate depressive symptoms according to the Beck Depression - -Inventory (BDI).
- Ability to understand the study procedures and intervention instructions.
- Willingness to participate in all intervention sessions.
- Ability and willingness to provide written informed consent.
You may not qualify if:
- Severe psychiatric disorders requiring specialized psychiatric care.
- Acute medical conditions that could prevent participation in the intervention.
- Receiving regular psychotherapy or another similar psychological intervention.
- Inability to understand the intervention instructions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Center for Strategic Studies and Health Training
Damascus, Damascus Governorate, Syria
Related Publications (6)
Winkley K, Upsher R, Stahl D, Pollard D, Brennan A, Heller SR, Ismail K. Psychological interventions to improve glycemic control in adults with type 2 diabetes: a systematic review and meta-analysis. BMJ Open Diabetes Res Care. 2020 Apr;8(1):e001150. doi: 10.1136/bmjdrc-2019-001150.
PMID: 32273289RESULTNewby J, Robins L, Wilhelm K, Smith J, Fletcher T, Gillis I, Ma T, Finch A, Campbell L, Andrews G. Web-Based Cognitive Behavior Therapy for Depression in People With Diabetes Mellitus: A Randomized Controlled Trial. J Med Internet Res. 2017 May 15;19(5):e157. doi: 10.2196/jmir.7274.
PMID: 28506956RESULTZarifsanaiey N, Jamalian K, Bazrafcan L, Keshavarzy F, Shahraki HR. The effects of mindfulness training on the level of happiness and blood sugar in diabetes patients. J Diabetes Metab Disord. 2020 Mar 2;19(1):311-317. doi: 10.1007/s40200-020-00510-7. eCollection 2020 Jun.
PMID: 32550181RESULTYang X, Li Z, Sun J. Effects of Cognitive Behavioral Therapy-Based Intervention on Improving Glycaemic, Psychological, and Physiological Outcomes in Adult Patients With Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials. Front Psychiatry. 2020 Jul 28;11:711. doi: 10.3389/fpsyt.2020.00711. eCollection 2020.
PMID: 32848906RESULTNi YX, Ma L, Li JP. Effects of mindfulness-based intervention on glycemic control and psychological outcomes in people with diabetes: A systematic review and meta-analysis. J Diabetes Investig. 2021 Jun;12(6):1092-1103. doi: 10.1111/jdi.13439. Epub 2020 Nov 22.
PMID: 33064926RESULTDiNardo MM, Greco C, Phares AD, Beyer NM, Youk AO, Obrosky DS, Morone NE, Owen JE, Saba SK, Suss SJ, Siminerio L. Effects of an integrated mindfulness intervention for veterans with diabetes distress: a randomized controlled trial. BMJ Open Diabetes Res Care. 2022 Mar;10(2):e002631. doi: 10.1136/bmjdrc-2021-002631.
PMID: 35346971RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
ZaynALsham M AlQatrangi, BPharm, MPH
Center for Strategic Studies and Health Training
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 17, 2026
First Posted
August 21, 2026
Study Start
October 26, 2025
Primary Completion
January 30, 2026
Study Completion
January 30, 2026
Last Updated
August 27, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared with other researchers because of privacy and confidentiality considerations and to protect the personal and health information of study participants.